In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations
Evgeny Gutkin, Filipp Gusev, Francesco Gentile, Fuqiang Ban, S. Benjamin Koby, Chamali Narangoda, Olexandr Isayev, Artem Cherkasov, Maria G. Kurnikova
Highlight
The Critical Assessment of Computational Hit-Finding Experiments (CACHE) Challenge is focused on identifying small molecule inhibitors of protein targets using computational methods.
Abstract
The Critical Assessment of Computational Hit-Finding Experiments (CACHE) Challenge is focused on identifying small molecule inhibitors of protein targets using computational methods. For the CACHE Challenge #1, the Leucine-Rich Repeat Kinase 2 (LRRK2) WD40 Repeat (WDR) domain was selected as the target for in silico hit-finding and optimization. Mutations in LRRK2 are the most common genetic cause of familial form of Parkinson's disease. The LRRK2 WDR domain is an understudied drug target with no known molecular inhibitors. We developed a framework for the high-throughput structure-based virtual screening of a chemically diverse small molecule space. Hit identification was performed using the large-scale Deep Docking (DD) protocol followed by absolute binding free energy (ABFE) calculations. ABFEs were computed using an automated molecular dynamics (MD)-based thermodynamic integration (TI) approach. 4.1 billion ligands from Enamine REAL were screened with DD followed by ABFEs computed by MD TI for 793 ligands. 76 ligands were prioritized for experimental validation. Our results demonstrate the efficacy of the combined DD and ABFE approaches for hit identification for a target with no previously known hits. This approach is widely applicable for the efficient screening of ultra-large chemical libraries as well as rigorous protein-ligand binding affinity estimation leveraging modern computational resources.
Keywords
Cite This Paper
@article{Gutkin2023,
author = {Gutkin, Evgeny and Gusev, Filipp and Gentile, Francesco and Ban, Fuqiang and Koby, S. Benjamin and Narangoda, Chamali and Isayev, Olexandr and Cherkasov, Artem and Kurnikova, Maria G.},
title = {In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations},
year = {2023},
doi = {10.26434/chemrxiv-2023-lnzvr},
url = {http://dx.doi.org/10.26434/chemrxiv-2023-lnzvr},
publisher = {American Chemical Society (ACS)},
keywords = {molecular dynamics, virtual screening, high-throughput},
researchAreas = {drug-discovery, experiment-automation},
researchArea = {drug-discovery},
highlight = {The Critical Assessment of Computational Hit-Finding Experiments (CACHE) Challenge is focused on identifying small molecule inhibitors of protein targets using computational methods.}
} Copied to clipboard!
Related Research Areas
Related Publications
In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations
(2024)
The Critical Assessment of Computational Hit-Finding Experiments (CACHE) Challenge series is focused on identifying small molecule inhibitors of protein targets using computational methods.
Active learning guided drug design lead optimization based on relative binding free energy modeling
(2022)
In silico identification of potent protein inhibitors commonly requires prediction of a ligand binding free energy (BFE).
Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds
Communications Chemistry, 5 (2022)
AbstractDeep generative neural networks have been used increasingly in computational chemistry for de novo design of molecules with desired properties.
Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling
J. Chem. Inf. Model., 63, 583–594 (2023)
Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling.
In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations
Chemical Science, 15, 8800–8812 (2024)
In this work, we combined Deep Docking and free energy MD simulations for the in silico screening and experimental validation for potential inhibitors of leucine rich repeat kinase 2 (LRRK2) targeting the WD40 repeat (WDR) domain.